Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
10,417 results
- Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic: Complete Statistical AnalysisIndependent statistical analysis of Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults: Complete Statistical AnalysisIndependent statistical analysis of Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05972733).
- Seroquel XR in Adults With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Seroquel XR in Adults With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00852631).
- Serratus Plane Block for Postoperative Pain Control: Complete Statistical AnalysisIndependent statistical analysis of Serratus Plane Block for Postoperative Pain Control: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02865928).
- Sert2Independent statistical analysis of A Trial of Sertraline in Young Children With Autism Spectrum Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Serum Levels of Bupivacaine in Autotransfusion Drains Following Total Joint Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Serum Levels of Bupivacaine in Autotransfusion Drains Following Total Joint Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Serum Markers in Gluten Challenge: Complete Statistical AnalysisIndependent statistical analysis of Serum Markers in Gluten Challenge: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00931892).
- Service Dog Training Program for Military Veterans With PTSD: Complete Statistical AnalysisIndependent statistical analysis of Service Dog Training Program for Military Veterans With PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03777020).
- SETSIndependent statistical analysis of Statins for the Early Treatment of Sepsis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00528580).
- Severe Renal Disease Study in Fabry Patients Treated With Fabrazyme: Complete Statistical AnalysisIndependent statistical analysis of Severe Renal Disease Study in Fabry Patients Treated With Fabrazyme: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00837824).
- Sevoflurane Concentrations in Children: Complete Statistical AnalysisIndependent statistical analysis of Sevoflurane Concentrations in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06510803).
- SEVOPROTECTIONIndependent statistical analysis of Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevorane in Adult Patients Required General Anesthesia for Surgery in Terms of Quality of Anesthesia and Its Influence on…
- Sex-related Differences in Arterial Stiffness in Type 2 Diabetics: Role of Uric Acid: Complete Statistical AnalysisIndependent statistical analysis of Sex-related Differences in Arterial Stiffness in Type 2 Diabetics: Role of Uric Acid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Sexual Function and Wellbeing in Males With Rectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sexual Function and Wellbeing in Males With Rectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01216202).
- SFA ISRIndependent statistical analysis of Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SGA-induced Metabolic Syndrome in Bipolar Youth: Complete Statistical AnalysisIndependent statistical analysis of SGA-induced Metabolic Syndrome in Bipolar Youth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01858948).
- SGA-POWERIndependent statistical analysis of Neuromuscular Changes In Small For Gestational Age Children During Somatropin Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SGI-110Independent statistical analysis of SGI-110 in Combination With Carboplatin in Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01696032).
- SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity Pilot: Complete Statistical AnalysisIndependent statistical analysis of SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity Pilot: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SGLT2iIndependent statistical analysis of SGLT2 Inhibition in Older Obese Adults With Pre-diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04401904).
- SH-DS01 on Fecal Metagenomic Stability: Complete Statistical AnalysisIndependent statistical analysis of SH-DS01 on Fecal Metagenomic Stability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04598295).
- SHAPEIndependent statistical analysis of Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00608062).
- Shared Decision Making About Medication Use for People With Multiple Health Problems: Complete Statistical AnalysisIndependent statistical analysis of Shared Decision Making About Medication Use for People With Multiple Health Problems: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Shared Decision Making in Parents of Children With Head Trauma: Head CT Choice: Complete Statistical AnalysisIndependent statistical analysis of Shared Decision Making in Parents of Children With Head Trauma: Head CT Choice: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Shared Healthcare Actions and Reflections Electronic Systems in Survivorship: Complete Statistical AnalysisIndependent statistical analysis of Shared Healthcare Actions and Reflections Electronic Systems in Survivorship: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04337203).
- SHAREDCareIndependent statistical analysis of Assessing and Addressing Follow-up Care Needs That Will Facilitate Care Transitions for Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SHARPENIndependent statistical analysis of SHARPEN - Parkinson's Disease Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05987540).
- SHARPSIndependent statistical analysis of Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-Surgically: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SHIELDIndependent statistical analysis of 38 Week Extension Study to CAIN457C2303: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01093846).
- SHIELDIndependent statistical analysis of Phase III Study in Refractory Behcet's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00995709).
- Shift-and-persist and Cardiometabolic Markers Among Women in Puerto Rico: Complete Statistical AnalysisIndependent statistical analysis of Shift-and-persist and Cardiometabolic Markers Among Women in Puerto Rico: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06250738).
- Shifting Salty Taste Preferences in Children: Complete Statistical AnalysisIndependent statistical analysis of Shifting Salty Taste Preferences in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02909764).
- SHINEIndependent statistical analysis of A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SHO-SAIKO-TO for Patients With Chronic Hepatitis C: A Phase II Study: Complete Statistical AnalysisIndependent statistical analysis of SHO-SAIKO-TO for Patients With Chronic Hepatitis C: A Phase II Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ShockPulse-SE vs. Trilogy Trial: Comparing the Performance of Two Intracorporeal Lithotripters for Removal of Large Renal Calculi: Complete Statistical AnalysisIndependent statistical analysis of ShockPulse-SE vs. Trilogy Trial: Comparing the Performance of Two Intracorporeal Lithotripters for Removal of Large Renal Calculi: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Shockwave Coronary Lithoplasty® Study (Disrupt CAD II): Complete Statistical AnalysisIndependent statistical analysis of Shockwave Coronary Lithoplasty® Study (Disrupt CAD II): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03328949).
- Shockwave Coronary Rx Lithoplasty® Study (Disrupt CAD I): Complete Statistical AnalysisIndependent statistical analysis of Shockwave Coronary Rx Lithoplasty® Study (Disrupt CAD I): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02650128).
- Short (5 Days) Versus Long (14 Days) Duration of Antimicrobial Therapy for Acute Bacterial Sinusitis in Children: Complete Statistical AnalysisIndependent statistical analysis of Short (5 Days) Versus Long (14 Days) Duration of Antimicrobial Therapy for Acute Bacterial Sinusitis in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD): Complete Statistical AnalysisIndependent statistical analysis of Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections: Complete Statistical AnalysisIndependent statistical analysis of Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00466817).
- SHOTIndependent statistical analysis of Screening for Hesitancy to Optimize Talk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02708745).
- Should Non-eosinophilic Asthmatic Subjects be Treated With Inhaled Corticosteroids?: Complete Statistical AnalysisIndependent statistical analysis of Should Non-eosinophilic Asthmatic Subjects be Treated With Inhaled Corticosteroids?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00509197).
- SHyNIndependent statistical analysis of Sleep, Hypertension, and Nocturia: a Multicomponent Approach for Comorbid Illnesses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05419830).
- SIBO-PDIndependent statistical analysis of Treating Bacterial Overgrowth in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02470780).
- SICAS-1Independent statistical analysis of Allergens in Inner-City Schools and Childhood Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01756391).
- Sick-Day Protocol to Improve Outcomes in Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Sick-Day Protocol to Improve Outcomes in Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03141905).
- SICOG 0109Independent statistical analysis of Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Side Effect Profiles of Brand Name Versus Generic Oral Contraceptives: Complete Statistical AnalysisIndependent statistical analysis of Side Effect Profiles of Brand Name Versus Generic Oral Contraceptives: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00775190).
- SiFALDIndependent statistical analysis of Role of Sildenafil for Fontan Associated Liver Disease (SiFALD) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03154476).